Restricted accessResearch articleFirst published online 2019-10
Successful Derivation of an Induced Pluripotent Stem Cell Line from a Genetically Nonpermissive Enhanced Green Fluorescent Protein-Transgenic FVB/N Mouse Strain
The embryonic stem cell line derivation from nonpermissive mouse strains is a challenging and highly inefficient process. The cellular reprogramming strategy provides an alternative route for generating pluripotent stem cell (PSC) lines from such strains. In this study, we successfully derived an enhanced green fluorescent protein (EGFP)-transgenic “N9” induced pluripotent stem cell (iPS cell, iPSC) line from the FVB/N strain-derived mouse embryonic fibroblasts (MEFs). The exposure of MEFs to human OCT4, SOX2, KLF4, and c-MYC (OSKM) transgenes via lentiviral transduction resulted in complete reprogramming. The N9 iPS cell line demonstrated all the criteria of a typical mouse PSC line, including normal colony morphology and karyotype (40,XY), high replication and propagation efficiencies, expression of the pluripotency-associated genes, spontaneous differentiation to three germ lineage-derived cell types, and robust potential of chimeric blastocyst formation. Taken together, using human OSKM genes for transduction, we report, for the first time, the successful derivation of an EGFP-expressing iPS cell line from a genetically nonpermissive transgenic FVB/N mouse. This cell line could provide opportunities for designing protocols for efficient derivation of PSC lines from other nonpermissive strains and developing mouse models of human diseases.
Get full access to this article
View all access options for this article.
References
1.
AbbeyD., and SeshagiriP.B. (2017). Ascorbic acid-mediated enhanced cardiomyocyte differentiation of mouse ES-cells involves interplay of DNA methylation and multiple-signals. Differentiation, 96, 1–14.
2.
BrookF.A., and GardnerR.L. (1997). The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. U.S.A. 94, 5709–5712.
3.
BuehrM., NicholsJ., StenhouseF., MountfordP., GreenhalghC.J., KantachuvesiriS. B, rookerG., MullinsJ., and SmithA.G. (2003). Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines. Biol. Reprod. 68, 222–229.
4.
BuehrM., and SmithA. (2003). Genesis of embryonic stem cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 358, 1397–1402.
5.
CarinhasN., BernalV., YokomizoA.Y., CarrondoM.J., OliveiraR., and AlvesP.M. (2009). Baculovirus production for gene therapy: The role of cell density, multiplicity of infection and medium exchange. Appl. Microbiol. Biotechnol. 81, 1041–1049.
6.
ChoH.J., LeeC.S., KwonY.W., PaekJ.S., LeeS.H., HurJ., LeeE.J., RohT.Y., ChuI.S., LeemS.H., KimY., KangH.J., ParkY.B., and KimH.S. (2010). Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood, 116, 386–395.
CormackB.P., ValdiviaR.H., and FalkowS. (1996). FACS-optimized mutants of the green fluorescent protein (GFP). Gene, 173, 33–38.
9.
CuiC., WaniM.A., WightD., KopchickJ., and StambrookP.J. (1994). Reporter genes in transgenic mice. Transgenic Res. 3, 182–194.
10.
DaviesT.J., and FairchildP.J. (2012). Optimization of protocols for derivation of mouse embryonic stem cell lines from refractory strains, including the non obese diabetic mouse. Stem Cells Dev. 21, 1688–1700.
11.
DevganV., and SeshagiriP.B. (2003). Successful development of viable blastocysts from enhanced green fluorescent protein transgene-microinjected mouse embryos: Comparison of culture media. Mol. Reprod. Dev. 65, 269–277.
12.
DevganV., ThomasM., UllasK.S., RaoM.R., and SeshagiriP.B. (2003). Embryo culture-based generation of enhanced green fluorescent protein-transgenic mice. Biochem. Biophys. Res. Commun. 303, 994–1001.
13.
EmigD., SalomonisN., BaumbachJ., LengauerT., ConklinB.R., and AlbrechtM. (2010). AltAnalyze and DomainGraph: Analyzing and visualizing exon expression data. Nucleic Acids Res. 38, W755–W762.
14.
EvansM.J., and KaufmanM.H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature, 292, 154–156.
15.
FrieseM.A., JensenL.T., WillcoxN., and FuggerL. (2006). Humanized mouse models for organ-specific autoimmune diseases. Curr. Opin. Immunol. 18, 704–709.
16.
FusakiN., BanH., NishiyamaA., SaekiK., and HasegawaM. (2009). Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 85, 348–362.
17.
GarbuttT.A., KonnekerT.I., KongantiK., HillhouseA.E., Swift-HaireF., JonesA., PhelpsD., AylorD.L., and ThreadgillD.W. (2018). Permissiveness to form pluripotent stem cells may be an evolutionarily derived characteristic in Mus musculus. Sci. Rep. 8, 14706.
18.
GuanC., YeC., YangX., and GaoJ. (2010). A review of current large-scale mouse knockout efforts. Genesis, 48, 73–85.
19.
HannaJ., MarkoulakiS., MitalipovaM., ChengA.W., CassadyJ.P., StaerkJ., CareyB.W., LengnerC.J., ForemanR., LoveJ., GaoQ., KimJ., and JaenischR. (2009). Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell, 4, 513–524.
20.
HansonP., MathewsV., MarrusS.H., and GraubertT.A. (2003). Enhanced green fluorescent protein targeted to the Sca-1 (Ly-6A) locus in transgenic mice results in efficient marking of hematopoietic stem cells in vivo. Exp. Hematol. 31, 159–167.
21.
HoganB., BeddingtonR., CostantiniF., and LacyE. (1994). In vitro manipulation of preimplantation embryos. In Manipulating the Mouse Embryo: A Laboratory Manual. B. Hogan, R. Beddington, F. Costantini and E. Lacy, eds. (Cold Spring Harbor Lab. Press, Plainview) pp. 189–216.
22.
HottaA., and EllisJ. (2008). Retroviral vector silencing during iPS cell induction: An epigenetic beacon that signals distinct pluripotent states. J. Cell. Biochem. 105, 940–948.
23.
Huangda W., ShermanB.T., and LempickiR.A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57.
24.
HuangfuD., MaehrR., GuoW., EijkelenboomA., SnitowM., ChenA.E., and MeltonD.A. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26, 795–797.
25.
KajiK., NorrbyK., PacaA., MileikovskyM., MohseniP., and WoltjenK. (2009). Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 458, 771–775.
26.
KauffmannA., GentlemanR., and HuberW. (2009). arrayQualityMetrics—a bioconductor package for quality assessment of microarray data. Bioinformatics, 25, 415–416.
27.
KressC., Vandormael-PourninS., BaldacciP., Cohen-TannoudjiM., and BabinetC. (1998). Nonpermissiveness for mouse embryonic stem (ES) cell derivation circumvented by a single backcross to 129/Sv strain: Establishment of ES cell lines bearing the Omd conditional lethal mutation. Mamm. Genome, 9, 998–1001.
28.
LiW., WeiW., ZhuS., ZhuJ., ShiY., LinT., HaoE., HayekA., DengH., and DingS. (2009). Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell, 4, 16–19.
29.
LiuJ., AshtonM.P., SumerH., O'BryanM.K., BrodnickiT.C., and VermaP.J. (2011). Generation of stable pluripotent stem cells from NOD mouse tail-tip fibroblasts. Diabetes, 60, 1393–1398.
30.
MaheraliN., AhfeldtT., RigamontiA., UtikalJ., CowanC., and HochedlingerK. (2008). A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell, 3, 340–345.
31.
MartinG.R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U.S.A. 78, 7634–7638.
32.
McWhirJ., SchniekeA.E., AnsellR., WallaceH., ColmanA., ScottA.R., and KindA.J. (1996). Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background. Nat. Genet. 14, 223–226.
33.
MinJ.Y., HuangX., XiangM., MeissnerA., ChenY., KeQ., KaplanE., RanaJ.S., OettgenP., and MorganJ.P. (2006). Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction. J. Thorac. Cardiovasc. Surg. 131, 889–897.
34.
MinJ.Y., YangY., ConversoK.L., LiuL., HuangQ., MorganJ.P., and XiaoY.F. (2002). Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 92, 288–296.
35.
MolyneauxK.A., StallockJ., SchaibleK., and WylieC. (2001). Time-lapse analysis of living mouse germ cell migration. Dev. Biol. 240, 488–498.
36.
NakagawaM., KoyanagiM., TanabeK., TakahashiK., IchisakaT., AoiT., OkitaK., MochidukiY., TakizawaN., and YamanakaS. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101–106.
37.
NarsinhK.H., PlewsJ., and WuJ.C. (2011). Comparison of human induced pluripotent and embryonic stem cells: Fraternal or identical twins? Mol. Ther. 19, 635–638.
38.
OkitaK., NakagawaM., HyenjongH., IchisakaT., and YamanakaS. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322, 949–953.
RobertsonE.J. (1987). Embryo-derived stem cell lines. In Teratocarcinomas and embryonic stem cells: A practical approach. E.J. Robertson, ed. (IRL Press, Oxford) pp. 71–112.
41.
RosenthalN., and BrownS. (2007). The mouse ascending: Perspectives for human-disease models. Nat. Cell Biol. 9, 993–999.
42.
SchoonjansL., KreemersV., DanloyS., MoreadithR.W., LarocheY., and CollenD. (2003). Improved generation of germline-competent embryonic stem cell lines from inbred mouse strains. Stem Cells, 21, 90–97.
43.
ShaoL., FengW., SunY., BaiH., LiuJ., CurrieC., KimJ., GamaR., WangZ., QianZ., LiawL., and WuW.S. (2009). Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res. 19, 296–306.
44.
ShimomuraO., JohnsonF.H., and SaigaY. (1962). Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. J. Cell. Comp. Physiol. 59, 223–239.
45.
SimmonsD. (2008). The use of animal models in studying genetic disease: Transgenesis and induced mutation. Nat. Educ. 1,70.
46.
SinghG., TotigerT.M., and SeshagiriP.B. (2012). Successful derivation of EGFP-transgenic embryonic stem cell line from a genetically non-permissive FVB/N mouse. Am. J. Stem Cells, 1, 163–173.
47.
StadtfeldM., and HochedlingerK. (2010). Induced pluripotency: History, mechanisms, and applications. Genes Dev. 24, 2239–2263.
48.
SunN., LeeA., and WuJ.C. (2009). Long term non-invasive imaging of embryonic stem cells using reporter genes. Nat. Protoc. 4, 1192–1201.
49.
SuzukiO., MatsudaJ., TakanoK., YamamotoY., AsanoT., NaikiM., and KusanagiM. (1999). Effect of genetic background on establishment of mouse embryonic stem cells. Exp. Anim. 48, 213–216.
50.
TakahashiK., TanabeK., OhnukiM., NaritaM., IchisakaT., TomodaK., and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861–872.
51.
TakahashiK., and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663–676.
52.
TaketoM., SchroederA.C., MobraatenL.E., GunningK.B., HantenG., FoxR.R., RoderickT.H., StewartC.L., LillyF., and HansenC.T. (1991). FVB/N: An inbred mouse strain preferable for transgenic analyses. Proc. Natl. Acad. Sci. U.S.A. 88, 2065–2069.
53.
ThomsonJ.A., Itskovitz-EldorJ., ShapiroS.S., WaknitzM.A., SwiergielJ.J., MarshallV.S., and JonesJ.M. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145–1147.
54.
TrokovicR., WeltnerJ., ManninenT., MikkolaM., LundinK., HämäläinenR., SuomalainenA., and OtonkoskiT. (2013). Small molecule inhibitors promote efficient generation of induced pluripotent stem cells from human skeletal myoblasts. Stem Cells Dev. 22, 114–123.
55.
VermaI., RashidZ., SikdarS.K., and SeshagiriP.B. (2017). Efficient neural differentiation of mouse pluripotent stem cells in a serum-free medium and development of a novel strategy for enrichment of neural cells. Int. J. Dev. Neurosci. 61, 112–124.
56.
WeiW., QingT., YeX., LiuH., ZhangD., YangW., and DengH. (2008). Primordial germ cell specification from embryonic stem cells. PLoS One 3,e4013.
57.
WernigM., LengnerC.J., HannaJ., LodatoM.A., SteineE., ForemanR., StaerkJ., MarkoulakiS., and JaenischR. (2008). A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 26, 916–924.
58.
WobusA.M., and BohelerK.R. (2005). Embryonic stem cells: Prospects for developmental biology and cell therapy. Physiol. Rev. 85, 635–678.
59.
YuJ., HuK., Smuga-OttoK., TianS., StewartR., SlukvinI.I., and ThomsonJ.A. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324, 797–801.
60.
YuJ., VodyanikM.A., Smuga-OttoK., Antosiewicz-BourgetJ., FraneJ.L., TianS., NieJ., JonsdottirG.A., RuottiV., StewartR., SlukvinI.I., and ThomsonJ.A. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917–1920.
61.
ZhouH., WuS., JooJ.Y., ZhuS., HanD.W., LinT., TraugerS., BienG., YaoS., ZhuY., SiuzdakG., SchölerH.R., DuanL., and DingS. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4, 381–384.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
